Recently, during a virtual meeting of a board-of-directors committee, the chair noticed one of the absent committee members had suddenly appeared in attendance.

So, you have decided to sell your business. Often this process starts with an inward reflection. You may have identified a good reason to sell, but many questions remain.

Trying cases is exhilarating. For as long as the trial lasts, the mind is singularly focused, awake and asleep (mostly awake), on one thing: Winning the case.

For decades, Depo-Provera has been presented as a game-changing contraceptive—a quick injection every three months that promised simplicity and effectiveness.

This fall, Robins Kaplan LLP, in collaboration with Public Counsel, Brown Goldstein & Levy, and Inner City Law Center, secured a historic legal victory for disabled homeless veterans in Los Angeles.

Alan Harter is the founder and CEO of Pactolus, a platform dedicated to knowledge-sharing and bespoke solutions tailored for discerning entrepreneurs and their high-net-worth families.

Today's cybersecurity environment demands that every business establish effective corporate data privacy and consumer information security systems and practices.

There would be no need for contracts if parties always reached a true and complete meeting of the minds, remembered what they agreed to do, and then did what they said they were going to do.

ONLINE SHOPPING has become increasingly popular in recent years. E-commerce sales surpassed $6.5 trillion in 2023 and are expected to total over $8.1 trillion by 2026...

Artificial Intelligence (AI) is the simulation of human intelligence processes by machines, such as computer systems for assistance in quickly answering complicated questions, researching a specific topic, or creating an image.

In the last few years, developments in U.S. patent damages law have emerged that may have an upward effect on the magnitude of reasonable royalty awards.

This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications.

This summer, the U.S. Department of Justice requested additional information on Alterra Mountain Co.'s planned acquisition of Arapahoe Basin, known as A-Basin, signaling the first DOJ challenge...

This chart summarizes the case name, drug, patents-in-suit, and publicly available terms for reported settlements in federal district court cases...

This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to the Hatch-Waxman Act.

This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA.